Skip to main content
MedPathMedPath Home
Clinical Trials/SLCTR/2017/041
SLCTR/2017/041
Completed
未知

A randomized controlled trial to compare the efficacy of furosemide and indapamide combination against furosemide and metalozone combination in the sodium excreting effect in congestive heart failure

Rehman Medical Institute0 sitesTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCongestive Heart Failure

Overview

Phase
未知
Intervention
Not specified
Conditions
Congestive Heart Failure
Sponsor
Rehman Medical Institute
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •New York Hear Association Grade –III
  • •New York Hear Association Grade \- IV
  • •Adults from 18years to 90years of both genders will be included

Exclusion Criteria

  • •Chronic Kidney Disease \- Ultrasonographic evidence of chronic kidney disease
  • •Chronic Liver Disease \- Ultrasonographic evidence of liver fibrosis
  • •Malnutrition\- serum albumin concentration of less than 3g/dl

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A clinical interventional study to compare the efficacy of two combined non invasive brain stimulation as motor enhancement therapy for upper extremity in brain attack due to blocked blood vessel cases of more than six months.Health Condition 1: I633- Cerebral infarction due to thrombosis of cerebral arteries
CTRI/2019/11/022009JIPMER
Not yet recruiting
Phase 4
To study different pain relief modalities in preterm neonates during heel-stickHealth Condition 1: P84- Other problems with newborn
CTRI/2023/09/057787Bharati Vidyapeeth Deemed University Medical College, Pune
Not yet recruiting
Not Applicable
A study to compare the effectiveness of Pericapsular nerve group block versus erector spinae plane block for pain control after hip surgery
CTRI/2022/11/047702ady Hardinge Medical College
Not yet recruiting
Not Applicable
to study the efficacy of pirfenidone in systemic sclerosis related interstitial lung diseaseHealth Condition 1: null- systemic sclerosis with interstitial lung disease
CTRI/2018/01/011449Post graduate institute of medical education and research
Recruiting
Phase 2
A study to compare two medicines for lung disease in scleroderma patients- Tofacitinib ascompared to Mycophenolate MofetilHealth Condition 1: M340- Progressive systemic sclerosis
CTRI/2024/05/067540Post Graduate Institute of Medical Education and Research Chandigarh